Arrowhead Pharmaceuticals, Inc. (ARWR)
86.74
-0.37
(-0.42%)
USD |
NASDAQ |
Aug 24, 16:00
86.74
0.00 (0.00%)
After-Hours: 19:19
Arrowhead Pharmaceuticals Debt to Equity Ratio : 2.956 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.956 |
| March 31, 2026 | 2.237 |
| December 31, 2025 | 1.21 |
| September 30, 2025 | 1.574 |
| June 30, 2025 | 1.366 |
| March 31, 2025 | 1.084 |
| December 31, 2024 | 16.58 |
| September 30, 2024 | 4.594 |
| June 30, 2024 | 1.374 |
| March 31, 2024 | 0.8265 |
| December 31, 2023 | 2.446 |
| September 30, 2023 | 1.413 |
| June 30, 2023 | 0.2268 |
| March 31, 2023 | 0.1853 |
| December 31, 2022 | 0.2178 |
| September 30, 2022 | 0.2047 |
| June 30, 2022 | 0.1787 |
| March 31, 2022 | 0.0566 |
| December 31, 2021 | 0.0679 |
| September 30, 2021 | 0.0625 |
| June 30, 2021 | 0.0553 |
| March 31, 2021 | 0.0534 |
| December 31, 2020 | 0.0459 |
| September 30, 2020 | 0.0458 |
| June 30, 2020 | 0.0433 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0301 |
| December 31, 2019 | 0.0297 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.0243 |
| June 30, 2018 | 0.0232 |
| March 31, 2018 | 0.0213 |
| December 31, 2017 | 0.0351 |
| September 30, 2017 | 0.0311 |
| June 30, 2017 | 0.0287 |
| March 31, 2017 | 0.028 |
| December 31, 2016 | 0.0274 |
| September 30, 2016 | 0.0285 |
| June 30, 2016 | 0.0554 |
| March 31, 2016 | 0.0087 |
| December 31, 2015 | 0.0076 |
| September 30, 2015 | 0.0069 |
| June 30, 2015 | 0.0062 |
| March 31, 2015 | 0.006 |
| December 31, 2014 | 0.0063 |
| September 30, 2014 | 0.0061 |
| June 30, 2014 | 0.0058 |
| March 31, 2014 | 0.0111 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Sarepta Therapeutics, Inc. | 0.6845 |
| Intellia Therapeutics, Inc. | 0.1009 |
| Denali Therapeutics, Inc. | 0.0451 |
| Twist Bioscience Corp. | 0.21 |
| Revolution Medicines, Inc. | 0.4568 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.112B |
| Total Liabilities (Quarterly) | 1.646B |
| Shareholders Equity (Quarterly) | 465.53M |
| Current Ratio | 5.899 |
| Net Debt Paydown Yield | -1.11% |